STADA to Acquire GSK’s OTC Portfolio for the Expansion of its Consumer Health Business in Europe

STADA to Acquire GSK’s OTC Portfolio for the Expansion of its Consumer Health Business in Europe

Shots:

  • STADA acquires GSK’s six brands containing five skin care/topical application and one pediatric cough remedy namely Oilatum, Eurax, Savlon Antiseptic Cream, Ceridal, Tixylix and Polytar. The transaction is expected to close in Aug 2019
  • The focus of the acquisition is to strengthen and expand STADA’s Consumer Health business in European Healthcare markets. Additionally, the amnufacturing of five skin care products will be transferred to Thornton & Ross (STADA acquired Thornton & Ross) having portfolio and expertise for same
  • Polytar is a coal-tar based dandruff shampoo, marketed as a Tarmed in Spain and Portugal. Eurax is a topical itch relief cream marketed in France, Italy and Norway including UK, Ireland and Hong Kong

Click here to read full press release/ article | Ref: STADA | Image: Twitter